Andy Pasternak
Nessuna posizione attualmente
Profilo
Andy Pasternak is currently an Independent Director at Endo, Inc. Previously, he held the position of Partner at Bain & Co., Inc. from 2008 to 2019 and Partner at Oliver Wyman, Inc. from 1998 to 2008.
He also served as the Chief Strategy Officer & Executive Vice President at Horizon Therapeutics Plc from 2019 to 2023.
Mr. Pasternak obtained his undergraduate degree from Northwestern University and his MBA from The University of Chicago.
Posizioni attive di Andy Pasternak
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Andy Pasternak
| Società | Posizione | Fine |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/10/2023 |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/10/2019 |
Oliver Wyman, Inc.
 Oliver Wyman, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marsh & McLennan Cos., Inc., Oliver Wyman, Inc. is a leading international management consulting firm. The company is based in New York, NY. The company combines deep industry knowledge and expertise to create breakthroughs for clients on their toughest issues. Nick Studer has been the CEO of the company since 2021. | Corporate Officer/Principal | 01/01/2008 |
Formazione di Andy Pasternak
| The University of Chicago | Masters Business Admin |
| Northwestern University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
Oliver Wyman, Inc.
Oliver Wyman, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marsh & McLennan Cos., Inc., Oliver Wyman, Inc. is a leading international management consulting firm. The company is based in New York, NY. The company combines deep industry knowledge and expertise to create breakthroughs for clients on their toughest issues. Nick Studer has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Andy Pasternak
